1. Ferrari, R., Ceconi, C., Curello, S., Cargnoni, A., Alfieri, O., Pardini, A., Marzollo, P., and Visioli, O., Oxygen free radicals and myocardial damage: protective role ofthiol-containing agents, Am. J. Med., 1991, vol. 91, pp. S95–S105.
2. Dolzhenko, M.N., To the question of the expediency of metabolic cardioprotection in the era of evidence-based medicine, ML, 2012, nos. 2–3 (88–89), pp. 1–8.
3. Spath, N.B., Mills, N.L., and Cruden, N.L., Novel cardioprotective and regenerative therapies in acute myocardial infarction: a review of recent and ongoing clinical trials, Future Cardiol., 2016, vol. 12, pp. 655–672.
4. Agadzhanyan, N.A., Polunin, I.N., Stepanov, V.K., and Polyakov, V.N., Chelovek v usloviyakh gipokapnii i giperkapnii (A Man under Hypocapnic and Hypercapnic Conditions), Astrakhan, Moscow, 2001.
5. Gridin, L.A., Modern ideas about physiological and medioprophilactic effects of hypoxia and hypercapnia, Meditsina, 2016, no. 3, pp. 45–68.